Sarah Wilson

BACKGROUND/OBJECTIVE: The Veterans Health Administration (VHA) PRIDE in All Who Served health education group (PRIDE) was developed to improve health equity and access to care for military veterans who are lesbian, gay, bisexual, transgender, queer, and/or other sexual/gender-diverse identities (LGBTQ+). This 10-week program rapidly spread to over 30 VHA facilities in 4 years. Veterans receiving PRIDE experience improved LGBTQ+ identity-related resilience and reductions in suicide attempt likelihood. Despite PRIDE's rapid spread across facilities, information is lacking on implementation determinants. The current study's goal was to clarify determinants of PRIDE group implementation and sustainment. METHODS: A purposive sample of VHA staff (N = 19) with experience delivering or implementing PRIDE completed teleconference interviews January-April 2021. The interview guide was informed by the Consolidated Framework for Implementation Research. Rapid qualitative matrix analysis was completed with methods to ensure rigor (e.g., triangulation and investigator reflexivity). RESULTS: Key barriers and facilitators of PRIDE implementation were heavily related to facility inner setting (what is happening inside the facility), including implementation readiness (e.g., leadership support for LGBTQ+-affirming programming, access to LGBTQ+-affirming care training) and facility culture (e.g., systemic anti-LGBTQ+ stigma). Several implementation process facilitators enhanced engagement at sites, such as a centrally facilitated PRIDE learning collaborative and a formal process of contracting/training for new PRIDE sites. DISCUSSION/CONCLUSION: Although aspects of the outer setting and larger societal influences were mentioned, the majority of factors impacting implementation success were at the VHA facility level and therefore may be more readily addressable through tailored implementation support. The importance of LGBTQ+ equity at the facility level indicates that implementation facilitation should ideally address institutional equity in addition to implementation logistics. Combining effective interventions with attention to local implementation needs will be required before LGBTQ+ veterans in all areas will benefit from PRIDE and other health equity-focused interventions.

OBJECTIVE: Chronic pain is a significant problem in patients living with hepatitis C virus (HCV). Tobacco smoking is an independent risk factor for high pain intensity among veterans. This study aims to examine the independent associations with smoking and HCV on pain intensity, as well as the interaction of smoking and HCV on the association with pain intensity. DESIGN/PARTICPANTS: Cross-sectional analysis of a cohort study of veterans of Operations Enduring Freedom/Iraqi Freedom/New Dawn (OEF/OIF/OND) who had at least one visit to a Veterans Health Administration (VHA) primary care clinic between 2001 and 2014. METHODS: HCV was identified using ICD-9 codes from electronic medical records (EMRs). Pain intensity, reported on a 0-10 numeric rating scale, was categorized as none/mild (0-3) and moderate/severe (4-10). RESULTS: Among 654,841 OEF/OIF/OND veterans (median age [interquartile range] = 26 [23-36] years), 2,942 (0.4%) were diagnosed with HCV. Overall, moderate/severe pain intensity was reported in 36% of veterans, and 37% were current smokers. The adjusted odds of reporting moderate/severe pain intensity were 1.23 times higher (95% confidence interval [CI] = 1.14-1.33) for those with HCV and 1.26 times higher (95% CI = 1.25-1.28) for current smokers. In the interaction model, there was a significant Smoking Status × HCV interaction (P = 0.03). Among veterans with HCV, smoking had a significantly larger association with moderate/severe pain (adjusted odds ratio [OR] = 1.50, P < 0.001) than among veterans without HCV (adjusted OR = 1.26, P < 0.001). CONCLUSIONS: We found that current smoking is more strongly linked to pain intensity among veterans with HCV. Further investigations are needed to explore the impact of smoking status on pain and to promote smoking cessation and pain management in veterans with HCV.

Traumatic brain injury (TBI) is a continuing concern for military treatment facilities operated by the Department of Defense (DoD), the Veterans Health Administration (VHA), and civilian health care providers who deliver services to U.S. active duty service members and veterans. Improvements in body armor and other protective gear worn in the combat environment have dramatically increased the likelihood of survival after blast exposure and other related injuries. Blast-related exposures and other mechanisms of sustaining TBI in both the deployed and nondeployed setting can be the source of an array of physiological, neurocognitive, and psychological disorders in military service members and veterans. The goals of this chapter are primarily threefold: 1) to describe common aftereffects of blast-related exposures in military personnel and other events that produce TBI, 2) to describe the many co-occurring disorders that complicate the medical and psychological symptom picture for those who have had blast exposures and deployment to war zones, and 3) to discuss the current approach for polytrauma rehabilitation and integrated care for U.S. active duty service members and 632veterans who have served in Operation Enduring Freedom (Afghanistan 2001-2014), Operation Iraqi Freedom (Iraq 2003-2011), and Operation New Dawn (Iraq 2011-present), hereafter referred to as OEF/OIF/OND. This chapter also focuses on mild traumatic brain injury (MTBI) as opposed to those who suffered moderate and severe TBI, given that the vast majority of military TBI falls into the mild category. In addition, this chapter underscores the clinical situation of “polytrauma” as relevant to military and veteran populations given the high frequency of co-occurring disorders that are seen in military and veteran treatment environments.